This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
148
All patients will receive standard of care but the study arm will also receive Bupivacaine-Meloxicam in addition.
Cincinnati Urogynecology Associates
Cincinnati, Ohio, United States
Trihealth (Good Samaritan Hospital, Bethesda North Hospital)
Cincinnati, Ohio, United States
To determine if use of bupivacaine-meloxicam reduces post-operative narcotic use over the first 3 days following surgery
Pain medication diary
Time frame: 72 hours post surgery
Compare average pain on each day post operatively
11-point Numeric Rating Scale (NRS) for tracking pain using an illustrated figure to localize the pain, a 5-point Likert scale for satisfaction with pain control a Quality of Recovery (QoR-15) questionnaire filled out before surgery and on post-operative days 1 and 3
Time frame: 72 hours post surgery
Compare worst pain on each day post operatively
11-point Numeric Rating Scale (NRS) for tracking pain using an illustrated figure to localize the pain, a 5-point Likert scale for satisfaction with pain control a Quality of Recovery (QoR-15) questionnaire filled out before surgery and on post-operative days 1 and 3
Time frame: 72 hours post surgery
Compare satisfaction with pain control post operatively
11-point Numeric Rating Scale (NRS) for tracking pain using an illustrated figure to localize the pain, a 5-point Likert scale for satisfaction with pain control a Quality of Recovery (QoR-15) questionnaire filled out before surgery and on post-operative days 1 and 3
Time frame: 72 hours post surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.